Yong He

740 citations
56 papers · 577 indexed · h-index 15
Topics
Peptidase Inhibition and Analysis (19 papers)Protease and Inhibitor Mechanisms (8 papers)Advanced biosensing and bioanalysis techniques (7 papers)
Partner nations
ChinaUnited StatesTaiwan

In The Last Decade

Yong He

52 papers receiving 572 citations

Peers

Yong He
Comparison fields: 5 of 74
  • Molecular Biology 284
  • Oncology 205
  • Cancer Research 125
  • Biomedical Engineering 109
  • Surgery 90
Replace Christiane Amendt with:
Christiane Amendt Germany
Roni Rayes Canada
Cristina Nieto‐Jiménez Spain
Zili An United States
Zhongyuan Yin China
Fuyuki Inagaki Japan
Jingxuan Liu United States
In San Kim South Korea
Samuel L. Rice United States
Steve Swenson United States
Yong He relative to Christiane Amendt Germany Christiane Amendt's profile →
Citations per field
00.5×
Christiane Amendt · 1×
Citations per year

Countries citing papers authored by Yong He

Since Specialization
Citations

This map shows the geographic impact of Yong He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong He more than expected).

Fields of papers citing papers by Yong He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong He. The network helps show where Yong He may publish in the future.

Co-authorship network of co-authors of Yong He

This figure shows the co-authorship network connecting the top 25 collaborators of Yong He. A scholar is included among the top collaborators of Yong He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong He. Yong He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 1
5 18
6 15
7 0
8 2
9 28
10 2
11 8
12 1
13 36
14 5
15 45
16 18
17
Efficacy of ~(18)F-FDG PET/CT in diagnosis and prognosis for nasopharyngeal carcinoma patients during follow-up after comprehensive therapy
1
18 20
19 17
20 10

About Yong He

Yong He is a scholar working on Oncology, Cancer Research and Gastroenterology, having authored 56 papers that have together received 577 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (19 papers), Protease and Inhibitor Mechanisms (8 papers) and Advanced biosensing and bioanalysis techniques (7 papers). The work is most often cited by research in Cancer Research (125 citations), Oncology (205 citations) and Hematology (49 citations). Yong He has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Chongjiao Li, Yueli Tian, Bing Wen, Kemin Wang, Ke Quan, Xiaohai Yang, Jin Huang, Ping Lei, Le Ying and Yanjing Yang. Their work appears in journals such as PLoS ONE, Chemical Communications and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026